2001
DOI: 10.1093/bja/87.2.246
|View full text |Cite
|
Sign up to set email alerts
|

Isolated reduction of haematocrit does not compromise in vitro blood coagulation

Abstract: Low haematocrit values are generally well tolerated in terms of oxygen transport but a low haematocrit might interfere with blood coagulation. We thus sampled 60 ml of blood in 30 healthy volunteers. The blood was centrifuged for 30 min at 2000 g and separated into plasma, which contained the platelet fraction, and packed red blood cells. The blood was subsequently reconstituted by combining the entire plasma fraction with a mixture of packed red blood cells, 0.9% saline, so that the final haematocrit was eith… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
44
2

Year Published

2007
2007
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(54 citation statements)
references
References 24 publications
8
44
2
Order By: Relevance
“…This may relate to the presence of the enzyme elastase on the surface of RBC membranes, which may activate coagulation factor IX [236,237]. However, a moderate reduction of the Hct does not increase blood loss from a standard spleen injury [235], and an isolated in vitro reduction of the Hct did not compromise blood coagulation as assessed by thromboelastometry [238]. …”
Section: Resultsmentioning
confidence: 99%
“…This may relate to the presence of the enzyme elastase on the surface of RBC membranes, which may activate coagulation factor IX [236,237]. However, a moderate reduction of the Hct does not increase blood loss from a standard spleen injury [235], and an isolated in vitro reduction of the Hct did not compromise blood coagulation as assessed by thromboelastometry [238]. …”
Section: Resultsmentioning
confidence: 99%
“…This may relate to the presence of the enzyme elastase on the surface of RBC membranes, which may activate coagulation factor IX [225,226]. However, a moderate reduction of the Hct does not increase blood loss from a standard spleen injury [224], and an isolated in vitro reduction of the Hct did not compromise blood coagulation as assessed by thrombelastometry [227]. …”
Section: Resultsmentioning
confidence: 99%
“…However, this view is an oversimplification because systematic studies show a decreased maximum aggregation and a prolongation of aggregation time in thrombelastography in patients with iron deficiency anemia compared to controls [9,18], while isovolemic hemodilution leads to a shortening of reaction and coagulation times in a hematocrit dependent manner [16,21]. In this study only severe anemia was independently associated with CVT, which might be interpreted as a higher dependence of hypercoagulability on the hemoglobin and hematocrit levels rather than on the extent of thrombocytosis.…”
Section: Discussionmentioning
confidence: 99%